Verify any claim · lenz.io
Claim analyzed
Science“Leucine zipper EF-hand-containing transmembrane protein 1 (LETM1) was initially identified through studies investigating the genetic basis of Wolf–Hirschhorn syndrome (WHS).”
Submitted by Calm Zebra bd26
The conclusion
Open in workbench →The historical record supports this claim. LETM1 was first identified in gene-mapping and positional-cloning studies of the 4p16.3 region associated with Wolf–Hirschhorn syndrome, aimed at finding genes deleted in affected patients. A more precise wording would mention mapping of the WHS critical region, but the claim's core point remains accurate.
Caveats
- A more precise description is that LETM1 was identified through positional cloning/mapping of the WHS-associated 4p16.3 deletion region.
- The discovery was tied to finding genes deleted in WHS patients, not initially to functional studies of LETM1's mitochondrial role.
- Broad phrasing such as 'investigating the genetic basis' is accurate here, but it compresses a specific gene-discovery method into a general description.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
Nearly 2 decades since its discovery as one of the genes responsible for the Wolf-Hirschhorn Syndrome (WHS), the primary function of the leucine-zipper EF-hand containing transmembrane 1 (LETM1) protein in the inner mitochondrial membrane (IMM) or the mechanism by which it regulates mitochondrial Ca2+ handling is unresolved. The Letm1 gene was originally identified as one of the genes deleted in patients afflicted with the Wolf-Hirschhorn Syndrome (WHS), a contiguous gene deletion disorder marked by severe growth and intellectual disability, hypotonia, and seizures (Endele et al., 1999; Schlickum et al., 2004).
Leucine zipper EF‐hand containing transmembrane protein 1 (LETM1) is an inner mitochondrial membrane protein, whose exact function remains a point of contention since its identification in 1999. The constitutively expressed LETM1 gene was initially identified as part of a hemizygous microdeletion on the small arm of chromosome 4p16.3 found in patients with Wolf–Hirschhorn syndrome, a rare chromosomal disorder characterized by microcephaly, growth retardation, intellectual disability, and early onset of epileptic seizures.
Leucine Zipper EF-hand containing transmembrane protein-1 (LETM1) is an inner mitochondrial membrane protein that mediates mitochondrial calcium (Ca2+)/proton exchange. The constitutively expressed LETM1 gene was initially identified as part of a hemizygous microdeletion on the small arm of chromosome 4p16.3 found in patients with Wolf-Hirschhorn syndrome, a rare chromosomal disorder characterized by microcephaly, growth retardation, intellectual disability, and early onset of epileptic seizures.
The leucine zipper-, EF-hand-containing transmembrane protein 1 (LETM1) has recently been cloned in an attempt to identify genes deleted in Wolf-Hirschhorn syndrome (WHS), a microdeletion syndrome characterized by severe growth and mental retardation, hypotonia, seizures, and typical facial dysmorphic features. LETM1 is deleted in almost all patients with the full phenotype and has recently been suggested as an excellent candidate gene for the seizures in WHS patients.
LETM1 (leucine–zipper–EF hand-containing transmembrane region) encodes a mitochondrial protein conserved in all lower eukaryotes, animals, and plants. The WHS (MIM 194190) is a complex disease... caused by partial heterozygous deletion of the terminal portion of the short arm of chromosome 4 involving the 4p16.3 region. A subset of cases of WHS is characterized by seizures… The LETM1 gene has been localized less than 80 kb distal to the WHSCR-1 region, and it is invariably deleted in WHS patients with seizures and preserved in those without epilepsy (Schlickum et al., 2004)… Thus, LETM1 haploinsufficiency is a potential causative event for WHS with seizures.
The LETM1 gene provides instructions for making a protein whose function is not well understood. This protein is active in mitochondria, which are structures within cells that convert the energy from food into a form that cells can use. The LETM1 gene is located in a region of chromosome 4 that is deleted in people with the typical features of Wolf-Hirschhorn syndrome. LETM1, a novel gene encoding a putative EF-hand Ca(2+)-binding protein, flanks the Wolf-Hirschhorn syndrome (WHS) critical region and is deleted in most WHS patients.
Haploinsufficiency of LETM1, which encodes the mitochondrial protein leucine-zipper EF-hand-containing transmembrane protein 1 (LETM1), is thought to contribute to seizure development in WHS (Dimmer et al., 2008; Endele et al., 1999; Hasegawa and van der Bliek, 2007; McQuibban et al., 2010; Nowikovsky et al., 2004; Tamai et al., 2008). Wolf-Hirschhorn syndrome (WHS) is a contiguous gene deletion disorder caused by hemizygous deletion within chromosome 4p16.3. These findings provide the first direct evidence that cells with LETM1 haploinsufficiency obtained from individuals with WHS exhibit reduced LETM1 expression and that mitochondrial dysfunction is a consequence of the 50% reduction in LETM1 expression.
Wolf–Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome involving variable-sized deletions of the distal portion of the short arm of chromosome 4 (4p-). The critical region (WHSCR) was initially defined as a 165 kb region; later, a second critical region (WHSCR-2) was proposed. Among the genes in these regions, WHSC1 and LETM1 have been widely discussed as strong candidates for major features of WHS, with LETM1 particularly implicated in seizures.
By positional cloning in the 4p16.3 region associated with Wolf-Hirschhorn syndrome (WHS), we have identified a novel gene, LETM1, encoding a putative EF-hand Ca2+-binding protein. LETM1 flanks the WHS critical region and is deleted in most patients with the WHS phenotype. These findings suggest that LETM1 may be involved in the clinical features associated with WHS, particularly seizures.
The leucine zipper-, EF-hand-containing transmembrane protein 1 (LETM1) has recently been cloned in an attempt to identify genes deleted in Wolf-Hirschhorn syndrome (WHS), a microdeletion syndrome characterized by severe growth and mental retardation, hypotonia, seizures, and typical facial dysmorphic features. LETM1 is deleted in almost all patients with the full phenotype and has recently been suggested as an excellent candidate gene for the seizures in WHS patients.
By molecular analysis of terminal deletions of chromosome 4p, we defined a 165-kb critical region in 4p16.3 for Wolf-Hirschhorn syndrome. This region, designated WHSCR, is hemizygous in all patients showing the typical facial appearance and intellectual disability. The region is flanked by several genes, and subsequent work identified genes such as WHSC1 within WHSCR and LETM1 just distal to it as candidates for key WHS features.
Wolf-Hirschhorn syndrome (WHS) is caused by deletion of the Wolf-Hirschhorn critical region (WHSCR) within chromosome 4p16.3 by one of several genetic mechanisms. LETM1 is a proposed candidate gene for seizures that is deleted in almost all affected individuals. The diagnosis of Wolf-Hirschhorn syndrome is established in a proband by detection of a heterozygous deletion of the Wolf-Hirschhorn syndrome critical region (WHSCR) within 4p16.3.
Wolf-Hirschhorn syndrome (WHS) is a complex congenital syndrome caused by a monoallelic deletion of the short arm of chromosome 4. Seizures in WHS have been associated with deletion of LETM1 gene. LETM1 encodes for the human homologue of yeast Mdm38p, a mitochondria-shaping protein of unclear function.
Wolf-Hirschhorn syndrome is a contiguous gene deletion syndrome caused by partial deletion of chromosome 4p16.3. One deleted gene, LETM1, encodes a leucine zipper-EF-hand-containing putative mitochondrial protein and is a strong candidate for the seizure phenotype observed in the syndrome. Here we show that LETM1 functions as a mitochondrial Ca2+/H+ antiporter.
Wolf-Hirschhorn syndrome (WHS) is a well-known chromosome disorder caused by a deletion in the short arm of chromosome 4. A widely studied critical region is located at 4p16.3 and includes several genes, among them WHSC1 and LETM1, which have been proposed as candidates for some of the main clinical features of the syndrome, such as intellectual disability and seizures.
Leucine zipper-EF-hand containing transmembrane protein 1 (LETM1), a member of the LETM1/YOL027 gene family, was first identified by studies of the Wolf-Hirschhorn syndrome (WHS). LETM1 is located at chromosome 4p16.3 and is considered to be a candidate gene associated with the seizures that occur in WHS.
The gene now known as LETM1 was first reported in 1999 in a positional cloning study of the 4p16.3 region deleted in Wolf–Hirschhorn syndrome. In that work, the authors described LETM1 as a "novel gene" flanking the WHS critical region and noted that it is deleted in most WHS patients, indicating that the gene’s initial discovery was directly tied to investigating the genetic basis of Wolf–Hirschhorn syndrome.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
For developers
This same pipeline is available via API.
Verify your AI's output programmatically.
/extract pulls claims from text ·
/verify returns sourced verdicts ·
/ask answers follow-up questions.
Continue your research
Verify a related claim next.
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
The LETM1 gene was initially identified in 1999 through positional cloning and molecular analysis of the 4p16.3 chromosomal region to isolate genes deleted in patients with Wolf–Hirschhorn syndrome (Source 1, Source 2, Source 9). Multiple authoritative studies confirm that LETM1 was cloned and characterized specifically in these direct efforts to uncover the genetic basis of the syndrome's clinical features, particularly seizures (Source 4, Source 10).
The Proponent's case collapses into circular restatement: Source 1 (Frontiers in Physiology) and Source 2/3 (LETM1 EF-hand sensor paper) are secondary summaries that merely echo the WHS linkage narrative, so they cannot independently establish the historical pathway of “initial identification” beyond what the primary 1999 report already says. Critically, Source 9 (American Journal of Human Genetics) describes positional cloning “in the 4p16.3 region associated with” WHS and deletion in WHS patients, but that is evidence of locus-based mapping and subsequent implication—not proof that LETM1 was first identified through a syndrome-mechanism investigation as the motion's broader causal wording asserts, and Source 4/10 similarly describe cloning “in an attempt to identify genes deleted” without demonstrating that this was the gene's initial identification rather than one of several contemporaneous gene-discovery routes.
Argument against
The motion overstates the evidence: the primary discovery paper frames LETM1 as found by “positional cloning in the 4p16.3 region associated with” WHS (Source 9, American Journal of Human Genetics) rather than demonstrating it was “initially identified through studies investigating the genetic basis” of WHS specifically, which is a broader causal claim not actually proven by the cited text. Moreover, later reviews that repeat the WHS-origin story (e.g., Source 1 Frontiers in Physiology; Source 2/3) are secondary summaries and don't establish that WHS genetics was the initial identification route as opposed to a coincident mapping to a WHS-linked locus, so the motion's wording is misleading.
The Opponent's argument relies on a false dichotomy, as positional cloning of the 4p16.3 region associated with Wolf–Hirschhorn syndrome is inherently a study investigating the genetic basis of that syndrome. Furthermore, primary cloning papers explicitly state that LETM1 was cloned and identified in a direct attempt to isolate and identify genes deleted in Wolf–Hirschhorn syndrome patients (Source 4, Source 9, Source 10).
Expert review
3 specialized AI experts evaluated the evidence and arguments.
Expert 1 — The Logic Examiner
The logical chain from evidence to claim is direct and fully supported, as primary and secondary sources explicitly state that LETM1 was cloned and identified in direct attempts to isolate genes deleted in Wolf-Hirschhorn syndrome (Sources 4, 9, and 10). The opponent's argument relies on a semantic false dichotomy, falsely separating positional cloning of a syndrome's critical region from studies investigating that syndrome's genetic basis.
Expert 2 — The Context Analyst
The claim omits that LETM1 was identified specifically by positional cloning/mapping of the 4p16.3 microdeletion region in WHS patients (i.e., a locus-driven gene-finding effort) rather than by functional/mechanistic studies of WHS biology, but that distinction does not change the core historical point (Sources 9, 10, 4). With the full context restored, the overall impression remains accurate: LETM1's initial identification is tied to research aimed at defining genes deleted in Wolf–Hirschhorn syndrome, so the claim is mostly true rather than misleading (Sources 2, 1, 9).
Expert 3 — The Source Auditor
The most authoritative sources in this pool are high-authority peer-reviewed publications indexed on NIH PMC, PubMed, and a Johns Hopkins repository. Source 9 (American Journal of Human Genetics, 1999) is the original primary discovery paper and explicitly states LETM1 was identified 'by positional cloning in the 4p16.3 region associated with Wolf-Hirschhorn syndrome,' directly tying its initial identification to WHS research. Sources 1, 2, 3, 4, 10, and 16 — spanning peer-reviewed journals from 2001 to 2021 — consistently corroborate that LETM1 was 'initially identified' or 'first identified' through studies of WHS genetics, with Sources 4 and 10 explicitly stating it was 'cloned in an attempt to identify genes deleted in Wolf-Hirschhorn syndrome.' The Opponent's semantic argument — that positional cloning 'in the 4p16.3 region associated with WHS' is not the same as 'investigating the genetic basis of WHS' — is a distinction without a meaningful difference, as the entire purpose of positional cloning in that chromosomal region was to understand WHS. The claim is clearly and consistently confirmed by multiple independent, high-authority primary and secondary sources, with no credible source contradicting it.